[HTML][HTML] Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
JG Krueger, IB McInnes, A Blauvelt - Journal of the American Academy of …, 2022 - Elsevier
Plaque psoriasis is a common, chronic, systemic, immune-mediated inflammatory disease.
The Janus kinase-signal transducer and activator of transcription pathway plays a major role …
The Janus kinase-signal transducer and activator of transcription pathway plays a major role …
Interleukin 17 promotes angiotensin II–induced hypertension and vascular dysfunction
We have shown previously that T cells are required for the full development of angiotensin II–
induced hypertension. However, the specific subsets of T cells that are important in this …
induced hypertension. However, the specific subsets of T cells that are important in this …
Pathogenesis and clinical features of psoriasis
CEM Griffiths, JNWN Barker - The Lancet, 2007 - thelancet.com
Psoriasis, a papulosquamous skin disease, was originally thought of as a disorder primarily
of epidermal keratinocytes, but is now recognised as one of the commonest immune …
of epidermal keratinocytes, but is now recognised as one of the commonest immune …
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind …
CL Leonardi, AB Kimball, KA Papp, N Yeilding… - The Lancet, 2008 - thelancet.com
Background Interleukins 12 and 23 have important roles in the pathophysiology of psoriasis.
We assessed ustekinumab, a human monoclonal antibody directed against these cytokines …
We assessed ustekinumab, a human monoclonal antibody directed against these cytokines …
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with …
A Menter, A Gottlieb, SR Feldman… - Journal of the American …, 2008 - Elsevier
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin
and joint manifestations affecting approximately 2% of the population. In this first of 5 …
and joint manifestations affecting approximately 2% of the population. In this first of 5 …
Risk of myocardial infarction in patients with psoriasis
JM Gelfand, AL Neimann, DB Shin, X Wang… - Jama, 2006 - jamanetwork.com
ContextPsoriasis is the most common T-helper cell type 1 (TH1) immunological disease.
Evidence has linked TH1 diseases to myocardial infarction (MI). Psoriasis has been …
Evidence has linked TH1 diseases to myocardial infarction (MI). Psoriasis has been …
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind …
KA Papp, RG Langley, M Lebwohl, GG Krueger… - The Lancet, 2008 - thelancet.com
Background Ustekinumab, a human monoclonal antibody against interleukins 12 and 23,
has shown therapeutic potential for psoriasis. This study assessed the efficacy and safety of …
has shown therapeutic potential for psoriasis. This study assessed the efficacy and safety of …
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
Aims Psoriasis is a common chronic inflammatory T-helper cell-1/17 mediated skin disease.
Recent studies suggest that psoriasis, particularly if severe, may be an independent risk …
Recent studies suggest that psoriasis, particularly if severe, may be an independent risk …
IL-17A in psoriasis and beyond: cardiovascular and metabolic implications
E von Stebut, WH Boehncke, K Ghoreschi… - Frontiers in …, 2020 - frontiersin.org
Interleukin 17A (IL-17A) is one of the currently known six members of the IL-17 cytokine
family and is implicated in immune responses to infectious pathogens and in the …
family and is implicated in immune responses to infectious pathogens and in the …
The concept of psoriasis as a systemic inflammation: implications for disease management
K Reich - Journal of the European Academy of Dermatology …, 2012 - Wiley Online Library
Psoriasis is a systemic, immune‐mediated disorder, characterized by inflammatory skin and
joint manifestations. A range of co‐morbidities is associated with psoriasis, including …
joint manifestations. A range of co‐morbidities is associated with psoriasis, including …